Wedbush Reiterates Outperform on Generation Bio, Maintains $11 Price Target
Portfolio Pulse from richadhand@benzinga.com
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Generation Bio (NASDAQ:GBIO) and maintained a price target of $11.
August 04, 2023 | 1:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wedbush analyst has reiterated an Outperform rating on Generation Bio and maintained a price target of $11.
The reiteration of an Outperform rating by a reputable analyst like David Nierengarten from Wedbush is a positive signal for Generation Bio. The maintained price target of $11 also indicates confidence in the company's performance. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100